Désirée Louise Dräger
University of Rostock
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Désirée Louise Dräger.
Journal of Neuroscience Research | 2013
Veronica Antipova; Alexander Hawlitschka; Eilhard Mix; Oliver Schmitt; Désirée Louise Dräger; Reiner Benecke; Andreas Wree
Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from presynaptic vesicles through its proteinase activity cleaving the SNARE complex. Parkinsons disease (PD) is associated with locally increased cholinergic activity in the striatum. Therefore, the present study investigates the effect of unilateral intrastriatal BoNT‐A injection in naïve rats on striatal morphology; i.e., the total number of Nissl‐stained neurons and the volume of caudate‐putamen (CPu) were estimated. Furthermore, stainings for markers of gliosis (glial fibrillary acidic protein) and microglia (Iba1) were performed. In addition, the potential beneficial effects of a unilateral intrastriatal injection of BoNT‐A on motor activity in the rat model of hemi‐PD were evaluated. Hemi‐PD was induced by unilateral injection of 6‐hydroxydopamine (6‐OHDA) into the right medial forebrain bundle. Six weeks later, rats received an ipsilateral intrastriatal injection of BoNT‐A. Behaviorally, motor performance was tested. The total number of CPu neurons and the striatal volume were not significantly different between the BoNT‐A‐injected right and the intact left hemispheres of naïve rats. In hemi‐PD rats, intrastriatal BoNT‐A abolished apomorphine‐induced rotations, increased amphetamine‐induced rotations, and tended to improve left forelimb usage. Forced motor function in the accelerod test was not significantly changed by BoNT‐A, and open field activity was also unaltered compared with sham treatment. Thus, intrastriatal BoNT‐A affects spontaneous motor activity of hemi‐PD rats to a minor degree compared with drug‐induced motor function. In the future, tests assessing the cognitive and emotional performance should be performed to ascertain finally the potential therapeutic usefulness of intrastriatal BoNT‐A for PD.
Clinical Genitourinary Cancer | 2017
Désirée Louise Dräger; Chris Protzel; Oliver W. Hakenberg
Micro‐Abstract The psychological stress of patients with penile cancer arises from the cancer diagnosis per se and the corresponding consequences of treatment (loss of body integrity and sexual function). In addition, cancer‐specific distress ensues (eg, fear of metastasis, progression, relapse, death). The present study examined the effects of curative and palliative treatment on the psychological well‐being of patients with localized or advanced penile cancer using screening questionnaires to determine the consecutive need for psychosocial care. We undertook a prospective analysis of patients with penile cancer undergoing surgery or chemotherapy. The present study showed that patients with penile cancer have increased psychological stress and, consequently, an increased need for psychosocial care owing to the potentially mutilating surgery. Background: We examined the effects of treatment on the psychological well‐being of patients with localized or advanced penile cancer using screening questionnaires to determine the consecutive need for psychosocial care. Penile cancer is a rare, but highly aggressive, malignancy. The psychological stress of patients with penile cancer arises from the cancer diagnosis per se and the corresponding consequences of treatment. In addition, cancer‐specific distress results (eg, fear of metastasis, progression, relapse, death). Studies of the psychosocial stress of penile cancer patients are rare. Material and Methods: We undertook a prospective analysis of the data from patients with penile cancer who had undergone surgery or chemotherapy from August 2014 to October 2016 at our department. Patients were evaluated using standardized questionnaires for stress screening and the identification for the need for psychosocial care (National Comprehensive Cancer Network Distress Thermometer and Hornheider screening instrument) and by assessing the actual use of psychosocial support. Results: The average stress level was 4.5. Of all the patients, 42.5% showed increased care needs at the time of the survey. Younger patients, patients undergoing chemotherapy, and patients with recurrence were significantly more integrated with the psychosocial care systems. Finally, 67% of all patients received inpatient psychosocial care. Conclusion: Owing to the potentially mutilating surgery, patients with penile cancer experience increased psychological stress and, consequently, have an increased need for psychosocial care. Therefore, the emotional stress of these patients should be recognized and support based on interdisciplinary collaboration offered.
The Journal of Nuclear Medicine | 2016
Sascha Nitsch; Oliver W. Hakenberg; Martin Heuschkel; Désirée Louise Dräger; Guido Hildebrandt; Bernd J. Krause; Sarah M. Schwarzenböck
Early diagnosis and adequate staging are crucial for the choice of adequate treatment in prostate cancer (PC). Morphologic and functional imaging modalities, such as CT and MRI, have had limited accuracy in the diagnosis and nodal staging of PC. Molecular PET/CT imaging with 11C- or 18F-choline–labeled derivatives is increasingly being used, but its role in the diagnosis and initial staging of PC is controversial because of limitations in sensitivity and specificity for the detection of primary PC. For T staging, functional MRI is superior to 11C- or 18F-choline PET/CT. For N staging, 11C- or 18F-choline PET/CT can provide potentially useful information that may influence treatment planning. For the detection of bone metastases, 11C- or 18F-choline PET/CT has had promising results; however, in terms of cost-effectiveness, the routine use of 11C- or 18F-choline PET/CT is still debatable. 11C- or 18F-choline PET/CT might be used in high-risk PC before radiation treatment planning, potentially affecting this planning (e.g., regarding dose escalation). This review provides an overview of the diagnostic accuracy and limitations of 11C- or 18F-choline PET/CT in the diagnosis and staging of PC.
Journal of Voice | 2011
Désirée Louise Dräger; Ryan C. Branski; Andreas Wree; Lucian Sulica
Although Reinkes space, or layer, is a critical laryngeal structure, and the eponym is in current use in both clinical and research milieus, little is known about the life of the eponymist, German anatomist Friedrich Berthold Reinke. Extensive investigation of the archives at the University of Rostock and other sources, as well as multinational collaboration, has yielded unique insight into the personal and professional life of this pioneer who, among other things, identified and characterized the subepithelial space of the vocal fold and structures in the Leydig cells of the testicles and ovaries. This breadth of investigation reflects Reinkes intellectual curiosity and broad-ranging interest as well as his scientific environment. Without question, Reinkes observations of the human vocal fold are substantive contributions, without which modern laryngology could not have evolved. In 2009, at the 90th anniversary of Reinkes death, we summarize his achievements to express our appreciation for his singular brilliance and fundamental contribution to laryngology.
Nuklearmedizin | 2018
Désirée Louise Dräger; Martin Heuschkel; Chris Protzel; Andreas Erbersdobler; Bernd J. Krause; Oliver W. Hakenberg; Sarah M. Schwarzenböck
AIM Accurate staging of penile cancer requires invasive methods such as sentinel node biopsy or lymphadenectomy (LAD). We assessed the value of [18F]FDG PET/CT for non-invasive nodal staging in penile cancer (PC) patients before inguinal LAD. PATIENTS AND METHODS 41 consecutive patients with PC (stage pT1 or higher, cN0) received [18F]FDG PET/CT before undergoing bilateral modified or radical inguinal staging LAD. Lymph nodes with a visually increased [18F]FDG uptake were classified as suspicious of lymph node metastases (LNM). Standardized uptake value (SUV) of suspicious inguinal lymph nodes was determined. Results of [18F]FDG PET/CT were correlated with histopathology. RESULTS In total 623 lymph nodes were resected, in 10 patients LNM were histologically confirmed (14/623 lymph nodes). In patient-based analysis [18F]FDG PET/CT showed a sensitivity and specificity of 80% and 68 %, respectively, a positive predictive value (PPV) of 44 % and a negative predictive value (NPV) of 91 %. In the groin-based analysis, [18F]FDG PET/CT had a sensitivity of 69 %, a specificity of 77 %, a PPV of 36 % and a NPV of 93 %. There was no significant difference in SUVmean and SUVmax between true positive and false positive lymph nodes (p = 0.093 and 0.069, respectively). CONCLUSION [18F]FDG PET/ CT shows a high NPV in penile cancer patients without clinically evident LNM. However, due to its limited sensitivity (especially with respect to LNM of small size) and specificity (i. e. in the differentiation between (post)inflammatory and metastatic lymph nodes) [18F]FDG PET/CT cannot replace invasive nodal staging.
Deutsches Arzteblatt International | 2018
Oliver Walther Hakenberg; Désirée Louise Dräger; Andreas Erbersdobler; C.M. Naumann; Klaus-Peter Jünemann; Chris Protzel
BACKGROUND The incidence of penile cancer in Europe lies in the range of 0.9 to 2.1 cases per 100 000 persons per year. Carcinogenesis is associated with human papilloma virus (HPV) infection and with chronic inflammation. METHODS This review is based on publications (2010-2017) retrieved by a selective search in PubMed and EMBASE and on the guidelines of the European Association of Urology, the European Society of Medical Oncology, the National Comprehensive Cancer Network, and the National Institute for Health and Care Excellence (NICE). RESULTS 95% of cases of penile cancer are accounted for by squamous cell carcinoma, whose numerous subtypes have different clinical courses. Chronic preputial inflammation due to phimosis or lichen sclerosus is often associated with penile cancer. Circumcision lowers the risk of penile cancer (hazard ratio: 0.33). Maximally organ-preserving surgery with safety margins of no more than a few millimeters is the current therapeutic standard, because a local recurrence, if it arises, can still be treated locally with curative intent. Local radiotherapy can be performed in early stages. Lymphogenic metastasis must be treated with radical lymphadenectomy and adjuvant chemotherapy. Patients with clinically unremarkable inguinal lymph nodes nonetheless need invasive lymph node staging because of the high rate of lymphogenic micrometastasis. CONCLUSION Penile cancer is curable in all early stages with the appropriate treatment, but its prognosis depends crucially on the proper management of the regional (i.e., inguinal) lymph nodes. In many countries, the treatment of this rare disease entity has been centralized.
Therapeutic Advances in Urology | 2017
Désirée Louise Dräger; Chris Protzel; Andreas Erbersdobler; Oliver W. Hakenberg
journals.sagepub.com/home/tau 12
Journal of Geriatric Oncology | 2017
Désirée Louise Dräger; Chris Protzel; Oliver W. Hakenberg
BACKGROUND Two-thirds of all cancer cases affect patients who are older than 65years, yet the specific conditions of the treatment and supportive care in this age group are poorly studied. There are limited data on the specific psycho-oncological problems in elderly patients with genito-urinary cancers. The aim of this study was to investigate the psychosocial needs of elderly patients with genito-urinary tumors using screening questionnaires and to use such screening questionnaires for an in-patient psychosocial treatment program. METHODS Patients (≥65years, n=319) who underwent surgical (n=295) or medical treatment (n=24) for genito-urinary malignancies between 06/2014 and 11/2015 in our institution were included for prospective stress assessment. This was done with standardized questionnaires for stress screening and for the identification of need for care (NCCN Distress Thermometer and Hornheider Screening Instrument, HSI). RESULTS The patients scored an average of 4.4 on the Distress Thermometer. According to the survey evaluation, 28% of patients had need for psychosocial care. However, only a minority of patients (4%) did actually communicate any need for psychosocial care. We also assessed the actual utilization of inpatient psychosocial support which is offered to all patients. CONCLUSION There is a significant number of elderly patients with genito-urinary cancer with increased psychological stress and a consecutive need of psychosocial care. This is underreported and underused by the patients. Therefore, an easy low-threshold access system with an interdisciplinary and inter-professional collaborative support system would be desirable. Measuring psychological distress systematically can be helpful in treating older patients with malignant diseases.
Aktuelle Urologie | 2017
Désirée Louise Dräger; Sarah Zonnur; Andreas Erbersdobler; Chris Protzel; Oliver W. Hakenberg
Testicular and paratesticular cystadenomas arise from an oviduct-like structure, which, morphologically, is almost identical with the ovarian surface epithelium. These are very rare benign tumours of adults. They present as asymptomatic cystic lesions. Bilateral paratesticular cystadenomas are associated with the Von-Hippel-Lindau syndrome and may be associated with infertility. Most cystadenomas are benign, but a few cases of malignant transformation of embryonic remnants have been reported in the appendix testis, including cases of adenocarcinoma, cystadenocarcinoma, and a Müllerian-type epithelial tumour with a low malignant potential. We report the case of a 74-year-old man with a rare paratesticular cystadenoma of the male adnexa.
Journal of The European Academy of Dermatology and Venereology | 2016
Désirée Louise Dräger; Chris Protzel; Oliver W. Hakenberg
treatment tended to exhibit a more severe skin rash than those without nivolumab therapy. However, no significant difference was observed in the time to rash occurrence after vemurafenib administration between groups A and B. We believe that a close association exists between the severe skin rash and vemurafenib use with previous nivolumab treatment. In fact, in our patients, the severe skin rash did not appear when nivolumab was administered after vemurafenib treatment. Because vemurafenib has only recently been used to treat malignant melanoma, many patients may be switched from nivolumab to vemurafenib therapy. Therefore, assessing the patient’s skin is critical when making this change.